OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI | TechCrunch
OneCell Diagnostics has secured $16 million in a Series A round as it aims to limit cancer recurrence using AI advancements along with scientific ways.
© 2024 TechCrunch. All rights reserved. For personal use only.
